P
Protagonist Therapeutics D
D
PTGX
56.390
USD
0.01
(0.02%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
72
حجم السوق
3,495,162,442
الأخبار المقالات
العنوان: Protagonist Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.